Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy (AADSCTPL)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Irmandade Santa Casa de Misericórdia de Porto Alegre.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Irmandade Santa Casa de Misericórdia de Porto Alegre
ClinicalTrials.gov Identifier:
NCT00715546
First received: July 11, 2008
Last updated: June 21, 2011
Last verified: March 2009

July 11, 2008
June 21, 2011
October 2007
August 2011   (final data collection date for primary outcome measure)
Clinical evaluation of the transplanted area. [ Time Frame: one year ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00715546 on ClinicalTrials.gov Archive Site
Presence of neovascularization, adipose transplantation reabsorption, tissue viability [ Time Frame: one year ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
Phase 1 Study of Autologous-Derived Stem Cell Transplantation in Patients With Lipodystrophy

The aim of this study is to determine the safety of the autologous transplantation of adipose-derived stem cells in the treatment of lipodystrophies.

Not Provided
Interventional
Phase 1
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Lipodystrophy
Procedure: autologous transplantation of liposuction material enriched with adipose-derived stem cells
Lipoinjection enriched with adipose-derived stem-cells.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
5
November 2011
August 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • lipodystrophies with necessity of fat grafting
  • accept to participate of the study

Exclusion Criteria:

  • HIV infection
  • Metastatic malignancy
  • Body mass index < 20 kg/m²
  • Other severe systemic disease
Both
20 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Brazil
 
NCT00715546
ISCMPA 1642/07
Yes
Eduardo Mainieri Chem, Phd, Irmandade Santa Casa de Misericórdia de Porto Alegre
Irmandade Santa Casa de Misericórdia de Porto Alegre
Not Provided
Principal Investigator: Eduardo M. Chem, MD Irmandade Santa Casa de Misericórdia de Porto Alegre
Irmandade Santa Casa de Misericórdia de Porto Alegre
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP